225 related articles for article (PubMed ID: 31329927)
1. High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
Kano R; Aramaki C; Murayama N; Mori Y; Yamagishi K; Yokoi S; Kamata H
Med Mycol; 2020 Feb; 58(2):197-200. PubMed ID: 31329927
[TBL] [Abstract][Full Text] [Related]
2. Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
Kano R; Yokoi S; Kariya N; Oshimo K; Kamata H
Med Mycol; 2019 Apr; 57(3):346-350. PubMed ID: 29800467
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and genetic diversity of azole-resistant Malassezia pachydermatis isolates from canine otitis and dermatitis: A 2-year study.
Álvarez-Pérez S; Quevedo-Caraballo S; García ME; Blanco JL
Med Mycol; 2024 May; 62(5):. PubMed ID: 38734886
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
[TBL] [Abstract][Full Text] [Related]
5. Miconazole-tolerant strains of Malassezia pachydermatis generated by culture in medium containing miconazole.
Kano R; Kamata H
Vet Dermatol; 2020 Apr; 31(2):97-101. PubMed ID: 31729813
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Malassezia pachydermatis isolates from canine skin with atopic dermatitis to ketoconazole and itraconazole in East Asia.
Watanabe S; Koike A; Kano R; Nagata M; Chen C; Hwang CY; Hasegawa A; Kamata H
J Vet Med Sci; 2014 Apr; 76(4):579-81. PubMed ID: 24334863
[TBL] [Abstract][Full Text] [Related]
7. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
[TBL] [Abstract][Full Text] [Related]
8. An azole-resistant isolate of Malassezia pachydermatis.
Nijima M; Kano R; Nagata M; Hasegawa A; Kamata H
Vet Microbiol; 2011 Apr; 149(1-2):288-90. PubMed ID: 21074337
[TBL] [Abstract][Full Text] [Related]
9. Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin.
Yurayart C; Nuchnoul N; Moolkum P; Jirasuksiri S; Niyomtham W; Chindamporn A; Kajiwara S; Prapasarakul N
Med Mycol; 2013 Oct; 51(7):721-30. PubMed ID: 23547880
[TBL] [Abstract][Full Text] [Related]
10. Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan.
Murayama N; Kano R
J Vet Med Sci; 2023 Mar; 85(3):383-385. PubMed ID: 36724970
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal susceptibility of Malassezia pachydermatis strains isolated from dogs with chronic and acute otitis externa.
Chiavassa E; Tizzani P; Peano A
Mycopathologia; 2014 Oct; 178(3-4):315-9. PubMed ID: 25031085
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM
Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868
[TBL] [Abstract][Full Text] [Related]
13. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of amphotericin B-azole combinations against Malassezia pachydermatis strains.
Álvarez-Pérez S; García ME; Blanco JL
Med Mycol; 2019 Feb; 57(2):196-203. PubMed ID: 29534201
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibility of Malassezia pachydermatis biofilm.
Figueredo LA; Cafarchia C; Otranto D
Med Mycol; 2013 Nov; 51(8):863-7. PubMed ID: 23834283
[TBL] [Abstract][Full Text] [Related]
16. ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis.
Díaz L; Castellá G; Bragulat MR; Cabañes FJ
Mycopathologia; 2023 Apr; 188(1-2):21-34. PubMed ID: 36495417
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.
Cafarchia C; Figueredo LA; Iatta R; Colao V; Montagna MT; Otranto D
Med Mycol; 2012 Nov; 50(8):795-801. PubMed ID: 22471886
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.
Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF
Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535
[TBL] [Abstract][Full Text] [Related]
19. Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis.
Prado MR; Brito EH; Brilhante RS; Cordeiro RA; Leite JJ; Sidrim JJ; Rocha MF
J Microbiol Methods; 2008 Oct; 75(2):341-3. PubMed ID: 18603321
[TBL] [Abstract][Full Text] [Related]
20. In vitro algaecid effect of itraconazole and ravuconazole on Prototheca species.
Miura A; Kano R; Ito T; Suzuki K; Kamata H
Med Mycol; 2020 Aug; 58(6):845-847. PubMed ID: 31773164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
